Stimcell Energetics Reports Increased Losses and Financial Challenges for Six Months Ended November 30, 2025

Stimcell Energetics Inc. reported its financial results for the three and six months ended November 30, 2025, revealing a net loss of $309,748 for the quarter and $575,350 for the half-year period. This represents a significant increase in losses compared to the same periods in the previous fiscal year, where the company recorded losses of $139,508 and $206,427, respectively. The company's total operating expenses for the six months reached $545,400, a substantial rise from $190,334 in the prior year, primarily driven by increased general and administrative expenses, which surged to $303,082 from $39,132.

The company's balance sheet as of November 30, 2025, shows total assets of $52,345, up from $21,222 at the end of the previous fiscal year. Cash reserves increased to $46,159, compared to $14,581 in May 2025. However, total liabilities also rose significantly to $1,594,639 from $1,267,508, largely due to an increase in amounts due to related parties, which climbed to $546,447 from $448,536. The accumulated deficit has now reached $11,436,906, up from $10,861,556, indicating ongoing challenges in achieving profitability.

In terms of strategic developments, Stimcell Energetics completed a 1-for-15 reverse stock split on November 1, 2024, which reduced its authorized capital from 7.5 billion shares to 500 million shares. This move was part of a broader strategy to enhance the company's financial structure and market perception. The company also issued additional shares for services, increasing the total shares outstanding to 20,891,272 as of November 30, 2025, from 20,141,272 in May 2025.

Operationally, the company has not reported significant changes in customer counts or user statistics in this filing. However, it continues to focus on its core business of developing therapeutic and non-therapeutic products aimed at promoting wellness. The company has indicated that its future operations will depend on securing additional financing to meet its obligations and achieve profitable operations. Management plans to pursue funding through loans from directors and officers, promissory notes, and private placements of common stock.

Looking ahead, Stimcell Energetics acknowledges substantial doubt regarding its ability to continue as a going concern without additional financing. The company is actively seeking to improve its financial position and operational performance, but the outcome remains uncertain. The management's focus will be on navigating the current financial landscape while striving to enhance product development and market presence in the biotech sector.